Clinical Scorecard: Case Report: Development of Multiple Ground-Glass Nodules Following Lobectomy for Synchronous and Metachronous Multiple Primary Lung Cancer
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients with multiple GGNs and confirmed EGFR-sensitive mutations.
Care Setting
Key Highlights
Patient developed new GGNs after lobectomy for sMPLC.
EGFR L858R mutation identified in the patient.
EGFR-TKI therapy initiated for unresectable lesions.
Guideline-Based Recommendations
Diagnosis
Management
Consider EGFR-TKI therapy for unresectable GGN-type MPLC with confirmed EGFR mutations.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
EGFR-TKI therapy was initiated for the patient with unresectable lesions.
